| BSE: 500674 | Sector: Health care |
| NSE: SANOFI | ISIN Code: INE058A01010 |
| BSE 00:00 | 18 Jun | 5145.95 |
0.95 (0.02%) |
OPEN
5189.00 |
HIGH
5199.95 |
LOW
5110.00 |
| NSE 00:00 | 18 Jun | 5116.95 |
24.25 (0.48%) |
OPEN
5115.00 |
HIGH
5199.00 |
LOW
5100.00 |
| OPEN | 5189.00 |
| PREVIOUS CLOSE | 5145.00 |
| VOLUME | 84 |
| 52-Week high | 5995.00 |
| 52-Week low | 3901.00 |
| P/E | 34.01 |
| Mkt Cap.(Rs cr) | 11,851 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Aventis Pharma Ltd is a pharmaceutical company that discovers, develops and markets branded prescription drugs and vaccines to protect and improve the quality of life of people around the world. The company provides medicines for the treatment of patients in several therapeutic areas such as Cardiovascular Disease, Thrombotic Diseases, Metabolic Disorders, Oncology, Disorders of the Central Nervou...> More
| COMPANY INFORMATION | |||||||
| Non Executive Director : | Shailesh Ayyangar | ||||||
| Independent Director : | Rangaswamy R Iyer | ||||||
| Managing Director : | N Rajaram | ||||||
| Whole Time Director & CFO : | Lionel Guerin | ||||||
| Chairman : | Aditya Narayan | ||||||
| Independent Director : | Usha Thorat | ||||||
| Company Secretary : | Girish Tekchandani | ||||||
| Whole-time Director : | A Sood | ||||||
| Director : | Cyril Grandchamp-Desraux | ||||||
| Director : | Thomas Rouckout | ||||||
| AUDITOR : | Price Waterhouse & Co Chartered Accountants LLP | ||||||
| IND NAME : | Pharmaceuticals - Multinational | ||||||
| HOUSE NAME : | MNC Associate - Hoechst | ||||||
| Registered office | |||||||
| Sanofi Hse 117-B Saki Vihar Rd, L&T Business Park Powai,Mumbai,Maharashtra-400072 | |||||||
| Ph : 91-22-28032000 | |||||||
| WEBSITE : http://www.sanofindialtd.com | |||||||
| E-mail : igrc.sil@sanofi.com | |||||||
